Phase 2 Inflammatory Response Clinical Trials
7 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–7 of 7 trials
Recruiting
Phase 2
Effects of Cannabidiol and Tetrahydrocannabinol on Microbiome and Neuroinflammation in HIV
MicrobiomeHIVCannabis+3 more
University of California, San Diego90 enrolled1 locationNCT05514899
Recruiting
Phase 1Phase 2
Double-blind Pilot Study on the Effect of Anionic Exposome Enrichment (Biow) on Recovery and Sleep Quality in Postoperative Patients
Postoperative RecoveryInflammatory Response After Surgery
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz150 enrolled1 locationNCT06968000
Recruiting
Phase 1Phase 2
Cell Therapy With Treg Cells Obtained From Thymic Tissue (thyTreg) to Control the Immune Hyperactivation Associated With COVID-19 and/or Acute Respiratory Distress Syndrome (THYTECH2)
Systemic Inflammatory Response Syndrome
Hospital General Universitario Gregorio Marañon24 enrolled1 locationNCT06052436
Recruiting
Phase 2
Umbilical Mesenchymal Stromal Cells as Cellular Immunotherapy for Septic Shock
SepsisPathologic ProcessesInfections+4 more
Ottawa Hospital Research Institute296 enrolled2 locationsNCT05969275
Recruiting
Phase 2
PBM as Strategy to CABG Anemic Patients Bypass Graft (CABG)
Coronary DiseaseBleedingCoronary Artery Disease+5 more
Federal University of São Paulo120 enrolled1 locationNCT06542393
Completed
Phase 2Phase 3
Vitamin D dosing study in Intensive Care Unit patients
Systemic Inflammatory Response Syndrome
Dr Priya Nair50 enrolled1 locationACTRN12618000217202
Completed
Phase 2
Celecoxib affecting inflammation following thoracic and abdominal surgery (Phase II study)
Inflammatory response to surgery.
While the trial is being conducted at a cancer hospital, not all patients in this trial will be receiving cancer resection surgery. For instance, patients who have had colonic cancer resected and are receiving a follow-up procedure for repair of epigastric hernia, would be eligible.
Peter MacCallum Cancer Centre30 enrolled1 locationACTRN12615000041550